期刊文献+

药物贴剂治疗骨科疼痛 被引量:5

下载PDF
导出
摘要 肌肉骨骼疼痛牵涉部位多、持续时间长、影响劳动力,成为患者个人和社会的沉重负担,其治疗事关民生。药物治疗是处理肌肉骨骼疼痛的重要手段,而药物外用是首选方法,它具有使用方便、机体不良反应小的优点。研究表明,半合成的阿片类止痛剂丁丙诺啡(buprenorphine)克服了阿片类药物的不良反应,且戒断症状轻,脂溶性高,有利于皮肤渗透及制成透皮贴剂(BTDS)局部外用治疗慢性中度至重度腰背痛、骨关节炎痛等骨科疼痛及慢性非癌性疼痛。一系列随机对照临床研究证实BTDS的有效性和安全性,且疗效持久,耐受性好,用于老年患者不需要调整剂量,值得推崇和临床应用。
出处 《国际骨科学杂志》 2014年第3期137-139,共3页 International Journal of Orthopaedics
  • 相关文献

参考文献29

  • 1Dieppe P. Chronic musculoskeleaal pain[J]. BMJ, 2013, 346:f3146.
  • 2Foster NE, Hartvigsen J, Croft PP. Taking responsibility for the earlyassessment and treatment of patients with musculoskeletal pain: a review and critical analysis[J].Arthritis Res Ther, 2012, 14(1):205.
  • 3Borczuk P. An evidence based approach to the ebalution and treatment of low back pain in the emergency depanment[J ]. Emerg Med Pratt, 2013, 15(7):1- 23.
  • 4骨科常见疼痛的处理专家建议[J].中华骨科杂志,2008,28(1):78-81. 被引量:211
  • 5Likar R. Transdermal buprenorptfine in the management of persistent pain: safety aspects[J]. T her Clin Risk Manag, 2006 , 2(1 ):115- 125.
  • 6Sittl R. Transdermal buprenorphine in cancer pain and palliative care[J]. Palliat Med, 2006, 20(Suppl 1):s25-s30.
  • 7Davis MP. Twelve resons for considering buprenorphine as a frontline analgesic in the management of pain[J]. J Support Oncol, 2012, 10(6):209-219.
  • 8Bohrme K Buprenorphine in a transdermal therapeutic system: a new option[J]. Clin Rheumatol, 2002, 21 (Suppl 1) :S13-S16.
  • 9Wen W, l.ynch SY, Munera C, et al. Application site adverse events associated with the buprenorphine transdennal system: a pooled analysis[J]. Expert Opin Drug Saf, 2013, 12(3):309-319.
  • 10Kapil RP, Cipriano A, Friedman K, et al. Once-weekly transdernml buprenorphine application results in sustained and coiksistent steady state plasma levels[J]. J Pain Syng3tom Manage, 2013, 46(1):65-75.

二级参考文献24

  • 1Foley KM, Posner JB. Pain and its management. In: Wyngaarden JB, Smith LH. Cecil textbook of medicine. 18th ed. Philadelphia: WB Saunders Company, 1988. 104-112.
  • 2Bonica JJ. The management of pain of cancer. J Mich State Med Soc, 1953, 52: 284-290.
  • 3Merskey H, Watson GD. The lateralisation of pain. Pain, 1979, 7:271-280.
  • 4Merskey H. Logic, truth and language in concepts of pain. Qual Life Res, 1994, 3 Suppl 1: S69-76.
  • 5No authors listed. Recommendations for the medical management of osteoarthfitis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthfitis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 6Ong CK, Lirk P, Tan CH, et al. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res, 2007, 5: 19-34.
  • 7Bloodworth D. Issues in opioid management. Am J Phys Med Rehabil, 2005, 84(3 Suppl):S42-55.
  • 8Katz WA, Rothenberg R. Section 4: treating the patient in pain. J Clin Rheumatol, 2005, 11(2 Suppl): S16-28.
  • 9Stitik TP, Altschuler E, Foye PM. Pharmacotherapy of osteoarthritis. Am J Phys Med Rehabil, 2006, 85(11 Suppl): S15-28.
  • 10Fricke JR, Karim R, Jordan D, et al. A double-blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery. Clin Ther, 2002, 24: 953-968.

共引文献210

同被引文献64

  • 1田悦,郭善斌,赵平.80岁以上患者进行硬膜外镇痛的有效性和安全性[J].中国老年学杂志,2014,34(11):3028-3029. 被引量:5
  • 2许关煜.透皮贴剂及产品漫谈[J].中国处方药,2007,6(5):42-43. 被引量:4
  • 3周雪琼,林丽芬,陈伟珊.创伤骨科患者疼痛的护理对策[J].河北医学,2007,13(11):1363-1364. 被引量:11
  • 4骨科常见疼痛的处理专家建议[J].中华骨科杂志,2008,28(1):78-81. 被引量:211
  • 5刘传荣.药用透皮材料的制各与研究[D].上海工程技术大学,2014.
  • 6Plosker GL,Lyseng-Williamson A.Buprenorphine 5, 10 and 20 mug/h transdermal patch: a guide to its use in chronic non-malignant pain.CNS Drugs.2012;26(4):367-373.
  • 7Al-Tawil N,Odar-Cederlof I,Berggren AC,et al. Pharmacokinetics of transdermal buprenorphine patch in the elderly.Eur J Clin Pharm.2013;69(2):143-149.
  • 8Hamaguchi S,Ikeda T.Buprenorphine transdermal patch (Norspan tape).Masui.2013; 62(7):799-807.
  • 9Karlsson J,Soderstrom A,Augustini BG, et al.ls buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study.Curr Med Res Opin.2014;30(4): 575-587.
  • 10Schutter U,Ritzdorf I,Heckes B.The transdermal 7-day buprenorphine patch-an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study.MMW Fortschr Med.2010;152(31-33) :49.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部